Literature DB >> 2912946

The value of treatment planning using CT and an immobilizing shell in radiotherapy for paranasal sinus carcinomas.

H Tsujii1, T Kamada, Y Matsuoka, A Takamura, T Akazawa, G Irie.   

Abstract

This article describes a method which uses CT scans and immobilizing shells radiation treatment planning (CT-assisted planning) for paranasal sinus carcinomas and the value of this method on the treatment outcome. Results of the treatment for 82 patients who had CT-assisted planning were compared with that of 88 patients who had no such treatment planning. It has been concluded that the combined use of CT and the shell in treatment planning permitted a 3-dimensional localization of both the tumor and critical normal structures with great accuracy, leading to an improved long-term survival and a reduced complication rate. The multivariate regression analysis for predicting significant prognostic factors also confirmed the valuable role of CT in terms of survival and primary tumor control. The actuarial 5-year survival rate was 51% in all patients, whereas, by using CT-assisted planning, it was improved to 61%. The improved survival was observed among the patients with tumors of the suprastructures where tumors were located adjacent to the critical organs (brain and eye). Major complications attributable to radiation have included instances of brain and ocular damage. CT-assisted planning, however, has been proven effective in avoiding brain necrosis and preserving eye sight.

Entities:  

Mesh:

Year:  1989        PMID: 2912946     DOI: 10.1016/0360-3016(89)90037-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  1 in total

1.  Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.

Authors:  Takashi Mori; Rikiya Onimaru; Shunsuke Onodera; Kazuhiko Tsuchiya; Koichi Yasuda; Hiromitsu Hatakeyama; Hiroyuki Kobayashi; Shunsuke Terasaka; Akihiro Homma; Hiroki Shirato
Journal:  Radiat Oncol       Date:  2015-04-15       Impact factor: 3.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.